Patient ID,Sample ID,RUN,Sample Date,Reception date,Gender,Date of Birth,Diagnosis date,Country,Nationality,Ethnicity,City of resisdence,NHS number,HIV infection,Pipeline,Hospital Name,Initial Genotype,Genotype,Subtype,Genotyping CORE,Genotyping E1,Genotyping E2,Genotyping P7,Genotyping NS2,Genotyping NS3,Genotyping NS4A,Genotyping NS4B,Genotyping NS5A, Genotyping NS5B,Drug,Manufacturer,Therapy Class,Regime,Treatment date
1,H204820685,NGS91,2020-09-23,2020-09-29,Unknown,1971-04-08,2002-12-08,England,British,White,London,4657,No,PHE HCV bioinformatics pipeline,The Royal London Hospital,,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,dasabuvir,,,2 tablets per day,2020-08-08
24,H210360996,NGS91,2021-01-31,2021-02-06,Other,2055-10-04,1996-07-27,,Others,White,London,4680,No,PHE HCV bioinformatics pipeline,St George's Hospital,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,dasabuvir,,,2 tablets per day,2020-08-08
24,H210360996,NGS91,2021-01-31,2021-02-06,Other,2055-10-04,1996-07-27,,Others,White,London,4680,No,PHE HCV bioinformatics pipeline,St George's Hospital,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,simeprevir,Janssen,NS3A/4A protease inhibitor ,1 tablet per day,2019-04-05
24,H210360996,NGS91,2021-01-31,2021-02-06,Other,2055-10-04,1996-07-27,,Others,White,London,4680,No,PHE HCV bioinformatics pipeline,St George's Hospital,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,sofosbuvir,Gilead,NS5B nucleotide polymerase inhibitor,1 tablet per day,2019-04-05
90,H181680611,NGS93,2019-07-24,2019-07-30,Female,2066-12-08,1990-09-24,China,Chinese,White,,4746,Yes,PHE HCV bioinformatics pipeline,Nuffield Health Taunton Hospital,,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a
90,H181680611,NGS94_(repeat_Miseq_NGS93),2019-07-24,2019-07-30,Female,2066-12-08,1990-09-24,China,Chinese,White,,4746,Yes,PHE HCV bioinformatics pipeline,Nuffield Health Taunton Hospital,,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a
